New Market Study Published: Qatar Pharmaceuticals & Healthcare Report Q4 2012
BMI View: The future growth of Qatar's pharmaceutical market will remain constrained by small population numbers, although we expect that the planned overhaul of Qatar's public health strategy in the 2011-2016 period to increase per-capita spending on healthcare in general. While some downward pressure on prices are expected in the coming years, as part of the roll-out of the national insurance programme, the beneficiaries of the pharmaceutical market development will remain foreign players, as Qatar remains highly import-reliant.
View full press release